Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and beta carotene

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with beta carotene in 1 studies

Compound Research Comparison

Studies
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Trials
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Recent Studies (post-2010)
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Studies
(beta carotene)
Trials
(beta carotene)
Recent Studies (post-2010) (beta carotene)
319321248,3518832,673

Protein Interaction Comparison

ProteinTaxonomy2,3-bis(3'-hydroxybenzyl)butyrolactone (IC50)beta carotene (IC50)
Bile salt export pumpHomo sapiens (human)10
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)2.9512
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.6166

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfthan, G; Ariniemi, K; Erlund, I; Kilkkinen, A; Virtamo, J; Virtanen, MJ1

Trials

1 trial(s) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and beta carotene

ArticleYear
Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers.
    American journal of epidemiology, 2006, Apr-15, Volume: 163, Issue:8

    Topics: 4-Butyrolactone; Aged; alpha-Tocopherol; beta Carotene; Biomarkers; Case-Control Studies; Coronary Disease; Finland; Humans; Lignans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Smoking

2006